$AGN, $CLXT, $EIGR, $FE, $KALA
Below is a list of Wall Streets Top analysts upgrades, downgrades and initiations for Wednesday, as follows:
Allergan PLC (NYSE:AGN) was reiterated as Buy with a 280 price target at Argus.
Calyxt Inc. (NASDAQ:CLXT) was started as Buy and assigned a 16 price target at Jefferies, and Wells Fargo started coverage as Outperform with a 17 price target.
Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) was reiterated as Outperform and with a 34 price target at Wedbush Securities.
FirstEnergy Corp. (NYSE:FE) was raised to Outperform from In-Line at Evercore ISI.
Kala Pharmaceuticals Inc. (NASDAQ:KALA) was started as Outperform with a 46 price target at Wedbush. JPMorgan started coverage as Overweight and assigned a 35 price target. Merrill Lynch started it with a Buy rating and a $33 price objective.